We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,108 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8854,108 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,108
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.07%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
HWA
2226
Heartwood Wealth Advisors
Virginia
$1.41M +$2.17K +14 +0.1%
FNC
2227
First National Corp
Massachusetts
$1.41M -$65.4K -422 -4%
AWC
2228
Abundance Wealth Counselors
Pennsylvania
$1.41M +$56.1K +362 +4%
ATFA
2229
All Terrain Financial Advisors
Minnesota
$1.41M +$55.3K +357 +4%
WCM
2230
Winthrop Capital Management
Indiana
$1.4M +$1.52M +9,788 New
SFS
2231
Strategic Financial Services
New York
$1.4M -$201K -1,295 -12%
SIC
2232
Samalin Investment Counsel
New York
$1.4M -$27.9K -180 -2%
CPW
2233
Cove Private Wealth
New York
$1.4M +$187K +1,206 +14%
CPC
2234
Consolidated Planning Corp
Georgia
$1.4M +$557K +3,594 +59%
UOTTAIMCU
2235
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$1.4M +$50.1K +323 +3%
CFS
2236
CRA Financial Services
New Jersey
$1.4M -$66.6K -430 -4%
OFG
2237
Oxford Financial Group
Indiana
$1.4M -$259K -1,669 -15%
TCOTS
2238
Trust Company of the South
North Carolina
$1.4M +$72.8K +470 +5%
BRM
2239
Boston Research & Management
Massachusetts
$1.4M
LD
2240
Lipe & Dalton
New York
$1.4M +$31.3K +202 +2%
LWA
2241
Ledgewood Wealth Advisors
New Hampshire
$1.39M +$155 +1 +0%
TAI
2242
Terra Alpha Investments
District of Columbia
$1.39M +$1.49M +9,603 New
BC
2243
Barrett & Company
Rhode Island
$1.39M -$3.41K -22 -0.2%
PAG
2244
Powers Advisory Group
Illinois
$1.39M +$15.8K +102 +1%
WI
2245
Wedgewood Investors
Pennsylvania
$1.39M -$15.5K -100 -1%
MP
2246
Moment Partners
California
$1.38M +$1.48M +9,572 New
PWA
2247
Providence Wealth Advisors
Illinois
$1.38M +$4.65K +30 +0.3%
APG
2248
Abacus Planning Group
South Carolina
$1.38M -$161K -1,036 -10%
CCA
2249
Childress Capital Advisors
Texas
$1.38M -$36K -232 -2%
MWAM
2250
Manhattan West Asset Management
California
$1.38M -$14.6K -94 -1%

JNJ Hedge Fund Activity: Q4 2024 in Review

4,108 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,108 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,885 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.